Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.
Completed · Not applicable
Conditions studied: Gastroparesis
In brief
Kuvan® (sapropterin dihydrochloride) for Improving Gastric Accommodation in Women with Diabetic Gastroparesis (KIGA-DG)
Key facts
- Study ID
- NCT01135186
- Run by
- Stanford University
- People needed
- 9
- Starts
- 2010-05-01
- Expected to finish
- 2012-11-01
- Last updated by the study team
- 2019-09-10
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.